|
|||||
|
|
The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized,double-blind,placebo-controlled phase III trial |
|
| Authors: | Tilo Biedermann Piotr Kuna Petr Panzner Erkka Valovirta Morgan Andersson Frederic de Blay Dorthe Thrane Sanja Hald Jacobsen Brian Sonne Stage Lone Winther |
| Institution: | 1. Department of Dermatology and Allergology, Technical University of Munich, Munich, Germany;2. Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland;3. Department of Immunology and Allergology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic;4. Department of Pulmonary Diseases and Clinical Allergology, University of Turku, Turku, Finland;5. Terveystalo Allergy Clinic, Turku, Finland;6. Department of Otorhinolaryngology, Head and Neck Surgery, Skåne University Hospital, Lund, Sweden;7. Federation of Translational Medicine Chest Disease Department, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France;8. Global Clinical Development, ALK-Abelló, Hørsholm, Denmark;9. Allergy Clinic, Department of Dermato-Allergology, Gentofte Hospital, Copenhagen, Denmark |
| Abstract: |  |
| Keywords: | Allergic rhinoconjunctivitis allergy immunotherapy birch pollen clinical efficacy clinical trial safety sublingual immunotherapy tablet total combined score tree pollen AE Adverse event ARC Allergic rhinoconjunctivitis BPS Birch pollen season DMS Daily medication score DSS Daily symptom score EAACI European Academy of Allergy and Clinical Immunology ICH International Conference on Harmonisation RQLQ Rhinoconjunctivitis Quality of Life Questionnaire RQLQ(S) Rhinoconjunctivitis Quality of Life Questionnaire with Standardized Activities SLIT Sublingual immunotherapy TCS Total combined score (sum of rhinoconjunctivitis DSS and DMS) TPS Tree pollen season |
| 本文献已被 ScienceDirect 等数据库收录！ | |